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Assessment of mitral valve area by 3D echocardi-
ography in rheumatic mitral stenosis: Validation
of offline 3D planimetry measure
Alaa A. Mohamed, Ahmad Omran, MA. Hussein
Objectives: The aim of this study is to validate the
feasibility and accuracy of performing offline planimetric
measurement of mitral valve area (MVA) using real time
3-dimensional transesophageal echocardiography (3D
TEE), and to compare it with methods used routinely in
clinical practice: 2-dimensional (2D) planimetry and pres-
sure half time (PHT).
Background: Measurements of MVA by (2D) pla-
nimetry and Doppler (PHT) remain the mainstay meth-
ods used in routine clinical practice. 3D TEE provides
more improved accuracy and reproducibility over 2D
methods in theassessment of mitral valve morphology.
Planimetry of the MVA by 3D echocardiography has only
been done through multi-planar reconstruction of the
mitral valve orifice. However using offline 2D image cal-
ibration and measurement tools allows us to measure
MVA by 3D planimetry.
Methods: 45 patients with moderate to severe rheu-
matic mitral stenosis were referred for transthoracic and
transesophageal (TEE) echocardiography 2D and 3D. Off-
line planimetric measurement of MVA obtained from
real time 3D TEE zoom views of the mitral valve from
both left atrial (MVA 3DPLA) and left ventricular side
(MVA 3DPLV) were compared to MVA by 2D planimetry
and PHT. MVA measurements (2D and 3D) were
reported by two independent readers and interobserver
variability was assessed. MV areas measured by these
three methods were compared using Altman and Bland
methods and Shukla’s correlation.
Results: The Altman and bland analysis showed
consistency among all three measurements methods. 3
DTEE showed the least variability across different clini-
cians compared to 2 DTEE and PHT, Mean difference
0.08, 0.15, and .17, respectively.
Conclusion: 3DTEE planimetry appears to be a con-
sistent technique for measuring MVA and provides the
least variability in practical setting.
http://dx.doi:10.1016/j.jsha.2013.03.047
Kawasaki disease, delayed referral as a cause of
coronary artery affection
Ali A. Al-akhfash, Marwan Al Hawbani,
Abdulrahman A. Almesnid
Kawasaki disease (KD), an acute febrile vasculitis, is
the most common cause of acquired heart disease in
infants and young children. However, the diagnosis of
infantile KD can be difficult or delayed due to vague clin-
ical manifestations. This current study aimed to review
patients referred to pediatric cardiology at PSCC-Qassim
with a diagnosis or suspicion of Kaawasaki disease.
Methods: Retospectively review of the database as
well as patients files.
Results: During the period from August till 2009
August 2012, 23 patients were referred to PSCC-Q, with
a mean F/U period of 32 months. The mean age of pre-
sentation ±SD was 32 ± 28 months (range 5–96 months).
The timing of referral was ranging from 2 to 30 days from
the onset of fever. 13 patients were having complete cri-
teria for Kawasaki on presentation, 8 of them developed
cardiac affection. Out of the 22 patients referred 12 had
cardiac abnormality in the form of mitral insufficiency
in 2, aortic root dilatation in one and coronary artery
involvement in 6 patients. All patients except one
received IgG at a mean time from onset of fever of
10 ± 6 days (range 5–30 days). Two patients required a
second dose of IgG after 48 h from the first dose. Initial
echo was normal in 13. The most commonly affected cor-
onary artery was the LAD. ECG was abnormal in one.
Comparison between the groups with and without car-
diac affection was done. There was a difference in all
variables but did not reach a statistically significant
value.
Conclusion: A significant number of patients with
complete as well as incomplete Kawasaki had cardiac
involvement especially coronary atery affection. Delay
in the referral as well as in the administration of IgG
may lead to developement of coronary artery
involvement.
http://dx.doi:10.1016/j.jsha.2013.03.048
Survival outcome of 100 patients who underwent
transcatheter aortic valve implantation (TAVI)
Saeed Al Ahmari, Mohammed Al Otabi, Ali Al
Masood, Ahmed El Watidi, Moheeb Al Abdullah,
Husien Al Amri, Saad Al Kasab
Background: TAVI is a new alternative treatment
for high risk patients with severe aortic stenosis (AS).
The procedural success and survival have improved
over time. We report the survival data of 100 patients
who received TAVI at Prince Sultan Cardiac Center,
Riyadh.
Methods: Patient’s clinical, imaging and procedural
data were collected in a data base, and they were fol-
lowed at 6 month and yearly afterward. The survival data
were derived using statistical software
Results: 100 patients underwent the procedure with
mean age of 78.8 ± 8.8 years, 55% males, and 45 %
females. 60% of patient received Edward’s valve, and
40% received Core valve. The procedural success was
95%. The 30 days mortality was 10% in patients who
received Edward’s valve, and 5% in those received Core
valve. The 1-year mortality was 21% in patients received
Edward valve and 10% in those received Core valve. The
30 days mortality for patients who had trans-femoral
Edward approach was 9%, and for those who had
trans-apical approach was 11%. The 1-year mortality for
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